Updated data from Phase I study of antibody-drug conjugate EBC-129 released
- medicalxpress.com language
- 2025-06-03 16:57 event
- 2 months ago schedule

Domain EYEION.com for sale! This premium domain is available now at Kadomain.com
Metal screws are indispensable in bone surgery, but they can fail under everyday stress and complications can occur when screws loosen or even break. Until now, it has been difficult to accurately predict this risk because testing methods have not been able to simulate the real stresses in the body.
A recent study published in BMC Geriatrics analyzing health and long-term care insurance data from Tsukuba City has provided new insights into the prognosis of older patients who undergo invasive mechanical ventilation.
Air pollution is the second leading risk factor for death globally, with most of the world population subject to harmful air pollutant levels. However, the mechanisms behind air pollution affecting human health and mortality remain poorly understood, leaving treatment strategies unknown.
Millions of young women around the world face stigma and bias when seeking reproductive health services, often limiting their access to contraception and quality care. A new USC-led study conducted in over 200 clinics across Burkina Faso, Tanzania, and Pakistan shows that a focused intervention combining storytelling, peer support, and provider incentives can reduce this bias and expand contraceptive access for the young women who need it most.
Alcohol affects everyone differently, but new research reveals that biological sex may play a bigger role than previously thought.
A study conducted by researchers at the Center for Cell-Based Therapy (CTC) highlights key proteins and signaling pathways involved in the efficacy of immunotherapy based on CAR-T cells (lymphocytes modified in the laboratory to fight cancer).
As cannabis becomes more potent and widely used in the United States—especially among young adults—concerns about cannabis use disorder are growing. More than 16 million Americans meet the criteria, yet most never receive treatment.
A new study suggests that regularly eating a cup of beans a day may offer measurable benefits for heart and metabolic health. Incorporating beans into daily diets could serve as a simple, cost-effective way to reduce the risk of chronic diseases.
Research led by Aarhus University in Denmark reports that individuals with substance use disorders experience a heightened urge to move in response to music with complex rhythms and harmonies.
The Experimental Drug Development Center (EDDC), Singapore's national platform for drug discovery and development, has announced the presentation of updated clinical data for the ongoing Phase I trial for EBC-129 at the 2025 Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago.
Routine testing for multiple infectious diseases among migrants will benefit health care systems by identifying key infections earlier, a new study finds.
Spending time in or around nature can provide people suffering from chronic lower back pain with a degree of escapism that helps them better manage their physical discomfort, a new study has shown.
The effects of artificial intelligence on adolescents are nuanced and complex, according to a report from the American Psychological Association that calls on developers to prioritize features that protect young people from exploitation, manipulation and the erosion of real-world relationships.
A new type of mRNA vaccine is more scalable and adaptable to continuously evolving viruses such as SARS-CoV-2 and H5N1, according to a study by researchers at the University of Pittsburgh School of Public Health and the Pennsylvania State University. The study was published today in npj Vaccines.
Thousands more UK women who are having children have been diagnosed with an autoimmune condition now compared to the beginning of the millennium.
Extremely preterm newborns who weigh less than 3.3 pounds have immature lungs that often require high levels of ventilation oxygen in the hospital. This contributes to the chronic lung disease bronchopulmonary dysplasia, or BPD, the most common cause of death for these tiny infants. BPD exacts a devastating toll on the immature lung.
02 June 2025 Your Excellency, Dr Khaled Abdel Ghaffar, Minister of Health and Population of Egypt, Distinguished officials, Representatives of the Egyptian Vaccine Manufacturers Alliance, Colleagues and Partners, On behalf of the World Health Organization, I extend my warmest congratulations to Egypt for becoming the first country in the Eastern Mediterranean Region to achieve the regional target for hepatitis B control, as set by the Regional Committee Resolution EM/RC56/R.5 (2009). This recognition follows a rigorous review led by the independent Regional Validation Committee (RVC). Based on robust and verifiable data, the RVC concluded that Egypt has indeed met the regional target, supported by the following key indicators: Hepatitis B surface antigen (HBsAg) prevalence among children aged 5 years and older is below 1 per cent; Third-dose hepatitis B vaccine coverage maintained at 90 per cent or higher for over a decade; And birth dose coverage has exceeded 90 per cent for at least five years. These achievements are a testament to your leadership, sustained investment, and steadfast commitment to public health. I commend Your Excellency, the Ministry of Health and Population, and the dedicated teams driving Egypt’s national immunization and hepatitis control programmes. Egypt’s success represents not only a national achievement, but a regional milestone—a powerful example of what is possible when science, policy, and public trust align. Through your strong Expanded Programme on Immunization, you have significantly reduced vaccine-preventable diseases, improved child survival, and strengthened health systems—culminating in the elimination of measles and rubella. WHO stands ready to support you in introducing additional life-saving vaccines to protect against rotavirus, human papillomavirus, Read more...
It's never too late to start eating right as a means of protecting your brain health, a new study says.
The first-in-class antibody-drug conjugate (ADC) pivekimab sunirine (PVEK) demonstrated promising efficacy and high response rates for patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN), according to data from a Phase I/II study led by researchers from The University of Texas MD Anderson Cancer Center.